Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.42% | 1.93% | -7.14% | 2.79% | 7.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.42% | 1.93% | -7.14% | 2.79% | 7.33% |
| Cost of Revenue | 10.70% | 5.59% | -17.68% | -13.84% | -42.20% |
| Gross Profit | 1.50% | 0.78% | -4.18% | 8.03% | 38.69% |
| SG&A Expenses | 21.57% | 6.08% | 0.71% | 2.61% | 6.09% |
| Depreciation & Amortization | 32.03% | 22.09% | 18.88% | 23.25% | 46.61% |
| Other Operating Expenses | -8.27% | 27.71% | 22.42% | 25.83% | 20.19% |
| Total Operating Expenses | 18.00% | 8.89% | -4.54% | -5.32% | 4.97% |
| Operating Income | -24.48% | -16.14% | -15.94% | 27.41% | 12.14% |
| Income Before Tax | -82.20% | 21.37% | -119.21% | 23.57% | 6.48% |
| Income Tax Expenses | -68.04% | -17.68% | -128.63% | 45.28% | -5.13% |
| Earnings from Continuing Operations | -84.64% | 32.85% | -118.34% | 20.08% | 8.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.64% | 32.85% | -118.34% | 20.08% | 8.77% |
| EBIT | -24.48% | -16.14% | -15.94% | 27.41% | 12.14% |
| EBITDA | -16.37% | -10.23% | -9.83% | 23.54% | 13.81% |
| EPS Basic | -84.77% | 31.86% | -118.21% | 19.34% | 8.11% |
| Normalized Basic EPS | -27.82% | -18.65% | -14.41% | 33.47% | 13.08% |
| EPS Diluted | -84.76% | 31.10% | -118.30% | 19.17% | 8.25% |
| Normalized Diluted EPS | -28.21% | -19.04% | -14.17% | 33.39% | 13.16% |
| Average Basic Shares Outstanding | 0.82% | 0.75% | 0.69% | 0.62% | 0.62% |
| Average Diluted Shares Outstanding | 1.36% | 1.23% | 0.41% | 0.68% | 0.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |